Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,275
Closed -$292K 504
2016
Q4
$292K Sell
7,275
-3,284
-31% -$127K 0.03% 348
2016
Q3
$410K Buy
10,559
+144
+1% +$5.44K 0.04% 313
2016
Q2
$360K Buy
10,415
+484
+5% +$16.8K 0.03% 362
2016
Q1
$343K Buy
+9,931
New +$346K 0.03% 360
2013
Q4
Sell
-26,039
Closed -$537K 538
2013
Q3
$537K Buy
26,039
+496
+2% +$10.6K 0.02% 673
2013
Q2
$493K Buy
+25,543
New +$534K 0.02% 670

Other funds holding HOLX

First Citizens Bank & Trust's HOLX Position: Q1 2017 in Review

First Citizens Bank & Trust sold out of Hologic (HOLX) in Q1 2017, closing a stake of 7,275 shares — an estimated $292K sold.

First Citizens Bank & Trust first reported a position in HOLX in Q2 2013 and held it in 6 quarters. The position peaked at $537K in Q3 2013. 501 funds tracked by Wall St. Rank hold HOLX as of Q1 2017.

  • First Citizens Bank & Trust reported no remaining Hologic position as of Q1 2017 after selling out during the quarter.
  • First Citizens Bank & Trust sold 7,275 Hologic shares in Q1 2017, an estimated $292K.
  • First Citizens Bank & Trust first reported a position in Hologic in Q2 2013 and held it in 6 quarters.
  • First Citizens Bank & Trust's Hologic position peaked at $537K in Q3 2013.
  • 501 funds tracked by Wall St. Rank held Hologic as of Q1 2017.

Based on First Citizens Bank & Trust's 13F filing for Q1 2017, filed 25 Apr 2017.